Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: A randomized, double-blind, placebo-controlled trial

Mary E. Lynch; Alexander J. Clark; Jana Sawynok; Michael J.L. Sullivan

doi:10.1097/00000542-200507000-00021

Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: A randomized, double-blind, placebo-controlled trial

Mary E. Lynch, Alexander J. Clark, Jana Sawynok, Michael J.L. Sullivan

Neuroscience

Research output: Contribution to journal › Article › peer-review

130 Citations (Scopus)

Original language	English
Pages (from-to)	140-146
Number of pages	7
Journal	Anesthesiology
Volume	103
Issue number	1
DOIs	https://doi.org/10.1097/00000542-200507000-00021
Publication status	Published - Jul 2005

ASJC Scopus Subject Areas

Anesthesiology and Pain Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/00000542-200507000-00021

Cite this

@article{7211b05044d446dba9dde940970de9a6,

title = "Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: A randomized, double-blind, placebo-controlled trial",

author = "Lynch, {Mary E.} and Clark, {Alexander J.} and Jana Sawynok and Sullivan, {Michael J.L.}",

note = "Funding Information: Received from the Departments of Psychiatry and Anesthesiology, Dalhousie University, Halifax, Nova Scotia, Canada. Submitted for publication October 6, 2004. Accepted for publication March 15, 2005. Supported by Epicept Corporation, Englewood Cliffs, New Jersey. Presented in a workshop at the joint meeting of the Canadian and American Pain Societies in Vancouver, British Columbia, Canada, May 8, 2004. Dr. Sawynok holds a patent for topical antidepressants (other than amitriptyline) as analgesics (US patent No. 6,211,171). ",

year = "2005",

month = jul,

doi = "10.1097/00000542-200507000-00021",

language = "English",

volume = "103",

pages = "140--146",

journal = "Anesthesiology",

issn = "0003-3022",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes

T2 - A randomized, double-blind, placebo-controlled trial

AU - Lynch, Mary E.

AU - Clark, Alexander J.

AU - Sawynok, Jana

AU - Sullivan, Michael J.L.

N1 - Funding Information: Received from the Departments of Psychiatry and Anesthesiology, Dalhousie University, Halifax, Nova Scotia, Canada. Submitted for publication October 6, 2004. Accepted for publication March 15, 2005. Supported by Epicept Corporation, Englewood Cliffs, New Jersey. Presented in a workshop at the joint meeting of the Canadian and American Pain Societies in Vancouver, British Columbia, Canada, May 8, 2004. Dr. Sawynok holds a patent for topical antidepressants (other than amitriptyline) as analgesics (US patent No. 6,211,171).

PY - 2005/7

Y1 - 2005/7

UR - http://www.scopus.com/inward/record.url?scp=21744437460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21744437460&partnerID=8YFLogxK

U2 - 10.1097/00000542-200507000-00021

DO - 10.1097/00000542-200507000-00021

M3 - Article

AN - SCOPUS:21744437460

SN - 0003-3022

VL - 103

SP - 140

EP - 146

JO - Anesthesiology

JF - Anesthesiology

IS - 1

ER -

Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: A randomized, double-blind, placebo-controlled trial

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this